When I first met Max in Zurich in the fall of 1974, ''Switzerland'' seemed to be written all over him. I had just arrived from the United States, and his reserved politeness, his aversion to jokes, and his habit of neither wasting nor mincing his words all fitted the cliché of the Swiss German. My impression was reinforced when he told me that his paternal ancestors had been gunpowder manufacturers and he himself had served as an artillery officer in the Swiss Army. It was only later that I learned that about half of his genesand all of his mitochondrial ones-came from sea-faring Portuguese who had settled in Brazil sometime in the past. The two genomes entered this world united in Bahia on July 12, 1933 when little Max was born to the Swiss merchant Max Birnstiel and his Brazilian wife Dalila Varella. When Max was five, his parents decided to move to Switzerland in order to allow Max and his brother Fritz to get a solid education. Max attended primary school and gymnasium in Zurich and then enrolled at the Swiss Federal Institute of Technology with the goal of studying biology, a subject that had fascinated him since childhood. On the advice of the botanist Albert Frey-Wyssling, he majored in physical chemistry-at that time an unorthodox gradus ad Parnassum for an aspiring biologist. As Max tells it, he never regretted this choice, as it taught him to look at complex biological systems with a quantitative eye. After his doctoral thesis with Frey-Wyssling, he spent 3 1/2 years at the California Institute of Technology at Pasadena, working as a postdoctoral fellow with the botanist James Bonner. This stay at one of the world's premier scientific institutions brought him face to face with scientific giants such as Linus Pauling, George Beadle, Max Delbrü ck, and Renato Dulbecco and the first stirrings of the biological revolution. His postdoctoral work led to the discovery that the ribosomal RNA genes of the plant Pisum sativum were highly repetitive, existing in hundreds of copies. Max was never quite satisfied with his postdoctoral harvest even though it furnished the basis of some of his breakthrough discoveries soon to come. His collaboration at Caltech with the British biologist Margaret Chipchase on ribosomal RNA genes was also fruitful in other ways: the two married in 1961.
In 1963, Conrad H. Waddington recruited the promising young Swiss to the Epigenetics Research Group at the Genetics Department of the University of Edinburgh, where Max rapidly rose through the ranks from Lecturer all the way to Professor. Inspired by his postdoctoral work on plant ribosomal RNAs, Max, his PhD students Adrian Bird and Michael Grunstein, together with team members started investigating the repetitive ribosomal RNA genes of the South African toad Xenopus laevis. By hybridizing total Xenopus DNA to the two major Xenopus ribosomal RNAs and subjecting the hybrids to isopycnic centrifugation in cesium chloride gradients, they purified the reiterated RNA genes as complexes with their cognate RNAs-the first gene purification ever, well before the advent of gene cloning. The ribosomal RNA genes could also be purified directly by repeated gradient centrifugation because they had an unusually high G+C content and, hence, a higher buoyant density than the bulk DNA. By today's standards, methods for studying genes were still paltry, but Max and his team could show that the genes were located in the nucleolus in a head-to-tail tandem arrangement. By 1971, when he was promoted to professor, Max was already a major player in the new and competitive field of molecular biology.
When the University of Zü rich offered him a chair in molecular biology in 1972, the OPEC oil shock had not yet rocked the West and Switzerland was still basking in the glow of financial opulence. The offer was thus very generous but came with a hitch: the university had already given one of the molecular biology chairs to Charles Weissmann, and it seemed likely that a shared institute would be too confining a habitat for two stellar and strong-willed scientists. The Solomonic solution was to split the Institute into an Institute I, headed by Charles Weissmann, and an Institute II, headed by Max Birnstiel. Max was never quite at ease with this solution, but his resources at Zurich and his growing scientific reputation allowed him to attract an impressive cast of bright young scientists, including, among others, Carmen Birchmeier, Meinrad Busslinger, Rudolf Grosschedl, Walter Schaffner, and John L. Telford.
In Zurich, Max applied improved density gradient procedures to purifying the repetitive 5S RNA genes of Xenopus laevis and the five clustered histone genes of the sea urchin Psammechinus miliaris. Never before had protein-coding genes from a multicellular organism been purified and studied in such detail. But this tour de force marked the end of an era. By 1975, gene cloning had entered the scene, rendering gene purification by physical methods obsolete.
Although by that time Max had stopped doing experiments himself, he retained an amazing experimental intuition. Walter Schaffner recounts how Max thought up an ingenious trick of injecting DNA into oocyte nuclei, which turned out to be crucial in defining DNA elements regulating gene transcription and RNA processing. Another such suggestion led to an effective method for recovering intact RNA from Xenopus oocytes. And an impressive string of highly original studies, done together with his gifted collaborators, soon threw new light on the promoters of tRNA genes and the cis-regulatory sequences and transacting factors governing 3 0 end processing of mRNAs. Particularly exciting was the discovery together with Rudolf Grosschedl of a ''modulator'' element more than 100 nucleotides upstream of the histone H2A gene promoter. This element acted in an orientation-independent manner and was thus the first member of the ''enhancers'' studied later by others. In 1986, 14 years after his recruitment to Zü rich, the Birnstiel laboratory went from strength to strength, showing no sign of slowing down. Always the good scientific citizen, Birnstiel also served as Chairman of the EMBO Council and organized international conferences on gene regulation that drew large audiences from all over the world. Many honors began to come his way, including foreign membership in the US National Academy of Sciences, honorary doctorates and professorships, the prestigious Naegeli Prize, and, later, medals of all stripes and colors. By the mid-1980s, Max was an admired international figure and an icon of Swiss science.
Fate had other plans, however. At the suggestion of the Austrian biochemist Peter Swetly, the US biotech pioneer Genentech and the German pharmaceutical giant Boehringer Ingelheim decided to establish a biomedical research Institute in Vienna, a city not known as a center of biomedicine. The crucial point was to find a high-profile scientist courageous enough to move to Vienna and set up a research Institute there. I had just visited Max in Zü rich and sensed his eagerness for a change. When I asked him whether he would be willing to head a new, privately funded biomedical research institute, he was immediately interested. But when he then asked ''where is that institute going to be?'', my reply ''in Vienna'' seemed to offend him and he said ''no.'' Early the next morning, however, my phone rang-it was Max. ''Is the job still available?'' he asked. This tongue-incheek question and the enthusiastic reaction by the two founder companies opened a new chapter in Max's life and in Austrian biomedicine. Max was a perfect choice for the challenge. He accepted under the condition that the molecular biology departments of Vienna University (now the Max L. Perutz Laboratories) would move next to his new ''Institute of Molecular Pathology'' (IMP), which was to be erected at the site of a defunct manufacturing facility. This visionary demand spawned Austria's leading life science campus, which today houses the IMP, the Max L. Perutz Laboratories, and several biological research institutes of the Austrian Academy of Sciences, as well as biotech spin-offs. In no time, Max had recruited five first-rate young scientists as group leaders who were to shape the IMP during its crucial starting phase and beyond. Adrian Bird came from the MRC Laboratories in Edinburgh, Kim Nasmyth from the Laboratory of Molecular Biology in Cambridge, Hartmut Beug and Erwin Wagner from the European Molecular Biology Laboratory (EMBL) in Heidelberg, and Meinrad Busslinger accompanied Max from Zurich. By creating a set of core facilities, Max gave the young IMP an edge over its competitors and quickly propelled it into the top league of biomedical research centers.
At the IMP, Max continued his work on eukaryotic gene regulation but also ventured into new areas. He searched for new cancer vaccines by transfecting murine cells by means of inactivated adenovirus particles and transferrin-polycation conjugates in order to generate cytokine-secreting autologous tumor cells. At work he was direct, demanding and imperial as ever, but Vienna also exposed his Brazilian heritage and the manifold layers of his complex persona. He had always appreciated the good things in life-wines, cigars, haute cuisine, and classical music-but now he could officially savor them with his many visitors. And he seemed to take mischievous pleasure in standing up to Austria's labyrinthine bureaucracy and mastering its mysterious titles. When he handed over the IMP directorship to Kim Nasmyth in 1996, he could look back to a period of astonishing achievement and personal happiness. After his return to Switzerland, he enjoyed traveling with his wife and children and playing classical music on his recorder. Early in 2014, he discovered a growth on his neck, which was diagnosed as an inoperable cancer. During the subsequent radiation treatment, his heart failed and he died on November 15 in a hospital near Wollerau, the Swiss village he had chosen for the final years of his eventful and brilliant life. 
